DCTH Straddle Strategy
DCTH (Delcath Systems, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions.
DCTH (Delcath Systems, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $446.7M, a trailing P/E of 830.86, a beta of 0.52 versus the broader market, a 52-week range of 8.12-13.724, average daily share volume of 436K, a public-listing history dating back to 2018, approximately 96 full-time employees. These structural characteristics shape how DCTH stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.52 indicates DCTH has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 830.86 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.
What is a straddle on DCTH?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current DCTH snapshot
As of June 30, 2026, spot at $12.66, ATM IV 69.10%, IV rank 11.45%, expected move 19.81%. The straddle on DCTH below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this straddle structure on DCTH specifically: DCTH IV at 69.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a DCTH straddle, with a market-implied 1-standard-deviation move of approximately 19.81% (roughly $2.51 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DCTH expiries trade a higher absolute premium for lower per-day decay. Position sizing on DCTH should anchor to the underlying notional of $12.66 per share and to the trader's directional view on DCTH stock.
DCTH straddle setup
The DCTH straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DCTH near $12.66, the first option leg uses a $12.66 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DCTH chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DCTH shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $12.66 | N/A |
| Buy 1 | Put | $12.66 | N/A |
DCTH straddle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
DCTH straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on DCTH. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use straddle on DCTH
Straddles on DCTH are pure-volatility plays that profit from large moves in either direction; traders typically buy DCTH straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
DCTH thesis for this straddle
The market-implied 1-standard-deviation range for DCTH extends from approximately $10.15 on the downside to $15.17 on the upside. A DCTH long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current DCTH IV rank near 11.45% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DCTH at 69.10%. As a Healthcare name, DCTH options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DCTH-specific events.
DCTH straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DCTH positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DCTH alongside the broader basket even when DCTH-specific fundamentals are unchanged. Always rebuild the position from current DCTH chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on DCTH?
- A straddle on DCTH is the straddle strategy applied to DCTH (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With DCTH stock trading near $12.66, the strikes shown on this page are snapped to the nearest listed DCTH chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DCTH straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the DCTH straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 69.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DCTH straddle?
- The breakeven for the DCTH straddle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DCTH market-implied 1-standard-deviation expected move is approximately 19.81%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on DCTH?
- Straddles on DCTH are pure-volatility plays that profit from large moves in either direction; traders typically buy DCTH straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current DCTH implied volatility affect this straddle?
- DCTH ATM IV is at 69.10% with IV rank near 11.45%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.